Literature DB >> 18949490

A novel multidrug therapy for difficult cyclosporine-resistant focal segmental glomerulosclerosis.

Eishin Oki, Kazushi Tsuruga, Masanobu Kudo, Koji Tsugawa, Koichi Suzuki, Hiroshi Tanaka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18949490     DOI： 10.1007/s00467-008-1033-5

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  9 in total

1.  Focal segmental glomerulosclerosis: unremitting proteinuria of long duration as a possible etiology?

Authors:  H Tanaka; S Waga; T Nakahata; N Onodera; N Monma
Journal:  Tohoku J Exp Med       Date:  2000-10       Impact factor: 1.848

2.  Tacrolimus for the treatment of focal segmental glomerulosclerosis resistant to cyclosporine A.

Authors:  Koichi Suzuki; Koji Tsugawa; Hiroshi Tanaka
Journal:  Pediatr Nephrol       Date:  2006-08-01       Impact factor: 3.714

3.  Immunosuppressive treatment of idiopathic focal segmental glomerulosclerosis: a five-year follow-up study.

Authors:  Dimitrios S Goumenos; George Tsagalis; A Meguid El Nahas; John R Shortland; Periklis Davlouros; John G Vlachojannis; Colin B Brown
Journal:  Nephron Clin Pract       Date:  2006-06-19

4.  Treatment of steroid-resistant focal segmental glomerulosclerosis with pulse methylprednisolone and alkylating agents.

Authors:  S A Mendoza; V M Reznik; W R Griswold; A M Krensky; P D Yorgin; B M Tune
Journal:  Pediatr Nephrol       Date:  1990-07       Impact factor: 3.714

5.  Mycophenolate mofetil in the treatment of focal segmental glomerulosclerosis.

Authors:  D C Cattran; M M Wang; G Appel; A Matalon; W Briggs
Journal:  Clin Nephrol       Date:  2004-12       Impact factor: 0.975

6.  Management of steroid-resistant focal segmental glomerulosclerosis in children using tacrolimus.

Authors:  Rajendra Bhimma; Miriam Adhikari; Kareshma Asharam; Catherine Connolly
Journal:  Am J Nephrol       Date:  2006-12-07       Impact factor: 3.754

Review 7.  Nephrotic syndrome and mizoribine in children.

Authors:  Masataka Honda
Journal:  Pediatr Int       Date:  2002-04       Impact factor: 1.524

8.  Effect of conversion from cyclosporine A to mizoribine on transplant arteriosclerosis in rat aortic allograft models.

Authors:  Hisashi Shimizu; Masafumi Takahashi; Shinichi Takeda; Kazunori Tahara; Seiichiro Inoue; Yoji Hakamata; Takashi Kaneko; Izumi Takeyoshi; Yasuo Morishita; Eiji Kobayashi
Journal:  Microsurgery       Date:  2003       Impact factor: 2.425

9.  Treatment of idiopathic membranous nephropathy with the combination of steroids, tacrolimus and mycophenolate mofetil: results of a pilot study.

Authors:  José Ballarin; Rafael Poveda; Jordi Ara; Laureà Pérez; Francesca Calero; Josep M Grinyó; Ramón Romero
Journal:  Nephrol Dial Transplant       Date:  2007-06-25       Impact factor: 5.992
  9 in total
  3 in total

1.  Addition of mizoribine to the prednisolone plus tacrolimus treatment regimen in a patient with lupus flare.

Authors:  Shojiro Watanabe; Kazushi Tsuruga; Tomomi Aizawa-Yashiro; Eishin Oki; Etsuro Ito; Hiroshi Tanaka
Journal:  Rheumatol Int       Date:  2011-03-23       Impact factor: 2.631

2.  Novel multidrug therapy for children with cyclosporine-resistant or -intolerant nephrotic syndrome.

Authors:  Tomomi Aizawa-Yashiro; Kazushi Tsuruga; Shojiro Watanabe; Eishin Oki; Etsuro Ito; Hiroshi Tanaka
Journal:  Pediatr Nephrol       Date:  2011-04-09       Impact factor: 3.714

Review 3.  Current understandings in treating children with steroid-resistant nephrotic syndrome.

Authors:  Jae Il Shin; Jun Oh; Jiwon M Lee; Andreas Kronbichler
Journal:  Pediatr Nephrol       Date:  2020-02-21       Impact factor: 3.714
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.